Analyst consensus rating
PDS Biotechnology Analyst Rating: Strong Buy
Direct answer
PDS Biotechnology's consensus rating is Strong Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.00.
Forecast evidence checked October 19, 2026.
Get free PDS Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.13
- Average price target
- $5.00
- High price target
- $5.00
- Low price target
- $5.00
- Low target gap
- +342.5%
- Target upside
- +342.5%
- High target gap
- +342.5%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for PDS Biotechnology?
PDS Biotechnology has a verified Strong Buy consensus. The same dataset has an average price target of $5.00.
How far are PDS Biotechnology's low and high targets from the recorded price?
The low target implies +342.5%, while the high target implies +342.5%.
How many analysts are included in PDS Biotechnology's consensus?
The verified consensus includes 1 analysts.
How is PDS Biotechnology's target upside or downside calculated?
The average target of $5.00 is divided by the recorded price of $1.13, then one is subtracted to produce +342.5%. This does not guarantee a future return.
When was PDS Biotechnology's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.